Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             110 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alterations in DHEA metabolism in schizophrenia: Two-month case-control study Ritsner, Michael
 2006
 16 Supplement 4 p. 137-146
10 p.
 artikel
2 Anxiety as a consequence of hypokinesia and its correction by afobazole Ashrafyan, K.
 2006
 16 Supplement 4 p. S92-S93
2 p.
 artikel
3 A review of antidepressant treatments today Kennedy, Sidney H.
 2006
 16 Supplement 4 p. S619-S623
5 p.
 artikel
4 Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders Yu, Younger W.-Y.
 2006
 16 Supplement 4 p. 498-503
6 p.
 artikel
5 Augmentation of antidepressant response by atypical antipsychotic drugs: electrophysiological studies in the rat brain Dremencov, E.
 2006
 16 Supplement 4 p. S29-S30
2 p.
 artikel
6 Author index 2006
 16 Supplement 4 p. S95-S98
4 p.
 artikel
7 C.16.02 Cape Town consensus statement on OC spectrum disorders Stein, D.J.
 2006
 16 Supplement 4 p. S586-
1 p.
 artikel
8 Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats Qu, Ying
 2006
 16 Supplement 4 p. 561-571
11 p.
 artikel
9 C.12.02 Is depression neurodegenerative? Schläpfer, T.E.
 2006
 16 Supplement 4 p. S581-
1 p.
 artikel
10 C.17.01 Lithium in mania: from John Cade to New Deli Study Rybakowski, J.
 2006
 16 Supplement 4 p. S587-
1 p.
 artikel
11 Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice Kuzmin, Alexander
 2006
 16 Supplement 4 p. 129-136
8 p.
 artikel
12 C.05.03 SNRIs in the treatment of fibromyalgia syndrome Gendreau, R.
 2006
 16 Supplement 4 p. S575-S576
2 p.
 artikel
13 C.01.01 Tracking patient remission and outcomes and treatment delivery in schizophrenia Van Os, J.
 2006
 16 Supplement 4 p. S571-
1 p.
 artikel
14 Depression and associated sleep disturbances: patient benefits with agomelatine Kupfer, David J.
 2006
 16 Supplement 4 p. S639-S643
5 p.
 artikel
15 Distinct gene expression profiles in adult rat brains after acute MK-801 and cocaine treatments Storvik, Markus
 2006
 16 Supplement 4 p. 211-219
9 p.
 artikel
16 2007 ECNP Workshop Announcement 2006
 16 Supplement 4 p. II-
1 p.
 artikel
17 Editorial Board 2006
 16 Supplement 4 p. ii-
1 p.
 artikel
18 Editorial Board 2006
 16 Supplement 4 p. CO2-
1 p.
 artikel
19 Editorial Board 2006
 16 Supplement 4 p. ii-
1 p.
 artikel
20 Effect of lithium on the deficit in performance of a reversal learning task induced by phencyclidine in the rat Idris, N.
 2006
 16 Supplement 4 p. S56-S57
2 p.
 artikel
21 Fluorescence in vitro studies of human dopamine d1 and d2 receptor proteins interaction Faron-Gorecka, A.
 2006
 16 Supplement 4 p. S4-S5
2 p.
 artikel
22 Is controversial efficacy of SSRI in treating depression in child and adolescent related to differences in study design? Usala, T.
 2006
 16 Supplement 4 p. S71-S72
2 p.
 artikel
23 Keyword Index 2006
 16 Supplement 4 p. S611-S617
7 p.
 artikel
24 Key Word Index (Volume 16) 2006
 16 Supplement 4 p. 631-641
11 p.
 artikel
25 Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokers Casey, Kevin F.
 2006
 16 Supplement 4 p. 512-520
9 p.
 artikel
26 Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission Micale, Vincenzo
 2006
 16 Supplement 4 p. 538-545
8 p.
 artikel
27 P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study Michelson, D.
 2006
 16 Supplement 4 p. S290-S291
2 p.
 artikel
28 P.1.a.005 Association studies of the CT repeat polymorphism in the cholecystokinin B receptor gene with the diagnosis and the response of pharmacotherapy in Korean patients with panic disorder Kim, W.
 2006
 16 Supplement 4 p. S210-S211
2 p.
 artikel
29 P.4.a.022 Association study of limbic system-associated membrane protein gene polymorphisms in panic disorder Maron, E.
 2006
 16 Supplement 4 p. S459-S460
2 p.
 artikel
30 P.6.a.009 Clinical signi .cation of pathological impulsivity in abstinent alcohol-dependent patients Jimenez, M.
 2006
 16 Supplement 4 p. S493-
1 p.
 artikel
31 P.8.a.026 Double blind trial of amantadine and haloperidol for treatment of delirium Kim, Y.R.
 2006
 16 Supplement 4 p. S548-
1 p.
 artikel
32 P.5.a.003 Effect of functional diet BT-11 (Polygala tenuifolia Willdenow) on subjective memory impairment and mild cognitive impairment in older people Kim, S.H.
 2006
 16 Supplement 4 p. S477-
1 p.
 artikel
33 P.3.a.027 In fluences of polymorphisms of beta adrenergic receptors in the psychopharmacological treatment of schizophrenia Spellmann, I.
 2006
 16 Supplement 4 p. S378-S379
2 p.
 artikel
34 P.8.a.044 Neuropsychological functioning in stabilised patients after a first psychotic episode Jimenez, A.
 2006
 16 Supplement 4 p. S557-S558
2 p.
 artikel
35 P.2.a.025 Predictors of response to vagus nerve stimulation Brodesser, D.
 2006
 16 Supplement 4 p. S296-S297
2 p.
 artikel
36 P.3.a.010 Risperidone long-acting injection: a one year observational study in a naturalistic setting Patel, M.X.
 2006
 16 Supplement 4 p. S369-S370
2 p.
 artikel
37 P.4.a.012 Should excessive worry be required for a diagnosis of generalized anxiety disorder? - Results from the US national comorbidity survey replication Ruscio, A.M.
 2006
 16 Supplement 4 p. S454-
1 p.
 artikel
38 P.8.a.012 Subtle cognitive impairments in siblings of male adolescents with non-psychotic psychiatric disorders Weiser, M.
 2006
 16 Supplement 4 p. S541-
1 p.
 artikel
39 P.2.a.001 The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder Kim, Y.
 2006
 16 Supplement 4 p. S283-
1 p.
 artikel
40 P.3.a.044 Tobacco, alcohol and cannabis use in Tunisian patients with schizophrenia Laqueille, X.
 2006
 16 Supplement 4 p. S388-S389
2 p.
 artikel
41 P.3.a.013 Untreated patients with schizophrenia have a failure of inhibitory control systems during saccadic tasks Krebs, M.O.
 2006
 16 Supplement 4 p. S371-
1 p.
 artikel
42 P.7.a.002 Use of levetiracetam in Asperger's Disorder patients: an open-label trial Mech, A.W.
 2006
 16 Supplement 4 p. S523-S524
2 p.
 artikel
43 P.8.a.030 Validation of a translational model of insomnia in rats and human volunteers Paterson, L.
 2006
 16 Supplement 4 p. S550-
1 p.
 artikel
44 P.8.b.002 Acetylcholine-mediated regulation of secretory cells is associated with calcium release from endoplasmic reticulum via InsPS-sensitive ion channels Kopach, O.V.
 2006
 16 Supplement 4 p. S564-S565
2 p.
 artikel
45 P.5.b.006 Age-dependent changes in hippocampal glutamate levels parallel learning impairment in APP/PS1 transgenic mice Minkeviciene, R.
 2006
 16 Supplement 4 p. S484-S485
2 p.
 artikel
46 P.2.b.008 Antidepressant-like activity of Wf-516, an antagonist of 5-HT1A receptors and inhibitor of 5-HT reuptake, in a chronic mild stress model of depression in rat Papp, M.
 2006
 16 Supplement 4 p. S305-S306
2 p.
 artikel
47 P.1.b.006 Characterization of Gpr101 expression and G protein-coupling selectivity Pausch, M.H.
 2006
 16 Supplement 4 p. S220-
1 p.
 artikel
48 P.2.b.005 Effect of chronic electroconvulsive shocks on Bcl-2 immunoreactivity in frontal cortex and nucleus accumbens Basar, K.
 2006
 16 Supplement 4 p. S304-
1 p.
 artikel
49 P.8.b.012 Hepatitis C, interferon and depression Granada, G.J.O.
 2006
 16 Supplement 4 p. S569-S570
2 p.
 artikel
50 P.3.b.009 Loss of latent inhibition in ovariectomized female rats: possible link to the oestrogen hypothesis of schizophrenia Arad, M.
 2006
 16 Supplement 4 p. S396-
1 p.
 artikel
51 P.6.b.008 Modulation of gabaergic transmission in alcoholic subjects and sons of alcoholics Dielentheis, T.F.
 2006
 16 Supplement 4 p. S500-
1 p.
 artikel
52 P.1.b.003 Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias? Fallgatter, A.J.
 2006
 16 Supplement 4 p. S218-S219
2 p.
 artikel
53 P.2.c.023 A comparison of unipolar depression treatment using antidepressants alone versus using antidepressants in combination with quetiapine (4 year follow-up) Hussain, M.Z.
 2006
 16 Supplement 4 p. S325-
1 p.
 artikel
54 P.1.c.047 A double-blind, placebo-controlled investigation of the anxiolytic effects of XBD173 (AC-5216) and alprazolam using a CCK-4-induced panic challenge Rupprecht, R.
 2006
 16 Supplement 4 p. S248-S249
2 p.
 artikel
55 P.1.c.007 Anti-aversive effect of endogenous opioid peptides-receptors blockade on innate and conditioned fear elicited by preys submitted to an aggressive encounter with South American rattlesnakes Coimbra, N.C.
 2006
 16 Supplement 4 p. S227-
1 p.
 artikel
56 P.2.c.036 A prospective study of the incidence and predictive factors of interferon induced neuropsychiatric disorders in hepatitis C patients Castellvi, P.C.A.
 2006
 16 Supplement 4 p. S332-
1 p.
 artikel
57 P.2.c.033 Clinical effectiveness of lamotrigine in recurrent major depressive disorder, resistant to other therapies Fricchione Parise, V.
 2006
 16 Supplement 4 p. S330-S331
2 p.
 artikel
58 P.3.c.041 −759 C/T polymorphism of the 5-HT2C receptor gene and antipsychotic drug-induced weight gain Ryu, S.H.
 2006
 16 Supplement 4 p. S418-S419
2 p.
 artikel
59 P.1.c.024 Effects of haloperidol on intracellular calcium ion change in hamster insulinoma cells Kim, M.H.
 2006
 16 Supplement 4 p. S236-S237
2 p.
 artikel
60 P.2.c.002 Efficacy of milnacipran augmentation of nicotine replacement therapy on post-cessation mood and anxiety in smokers with previous history of major depression Berlin, I.
 2006
 16 Supplement 4 p. S313-S314
2 p.
 artikel
61 P.3.c.058 Emotion recognition deficit in first-episode schizophrenic patients and atypical antipsychotics Amminger, G.P.A.
 2006
 16 Supplement 4 p. S427-S428
2 p.
 artikel
62 P.6.c.003 Methadone dose level influence on the efficiency of the treatment Ignjatova, L.
 2006
 16 Supplement 4 p. S502-
1 p.
 artikel
63 P.1.c.021 Monoamine oxidase B density is increased in the frontal cortex of suicide victims Callado, L.F.
 2006
 16 Supplement 4 p. S235-
1 p.
 artikel
64 P.3.c.003 Olanzapine versus ziprasidone in parenteral administration in psychotic relapse of schizophrenia Tudor, C.
 2006
 16 Supplement 4 p. S397-S398
2 p.
 artikel
65 P.3.c.027 Pattern of neuroleptic drug use in acute schizophrenia Gruenler, D.
 2006
 16 Supplement 4 p. S411-
1 p.
 artikel
66 P.1.c.034 Pharmacokinetics of licarbazepine in healthy volunteers: single and multiple oral doses and effect of food Souppart, C.
 2006
 16 Supplement 4 p. S242-
1 p.
 artikel
67 P.3.c.044 Plasma antioxidant status in first psychotic episode patients before and after antipsychotic treatment Rojas-Corrales, M.O.
 2006
 16 Supplement 4 p. S420-
1 p.
 artikel
68 P.1.c.048 The involvement of the descending dopaminergic pathway in the systemic cannabinoids, but not opioid-induced antinociception Dogrul, A.
 2006
 16 Supplement 4 p. S249-
1 p.
 artikel
69 P.3.c.013 The prevalence of bone mineral density loss in the Korean patients with chronic schizophrenia Shim, J.C.
 2006
 16 Supplement 4 p. S403-
1 p.
 artikel
70 P.2.c.019 Two-year maintenance treatment study assessing recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression Keller, M.
 2006
 16 Supplement 4 p. S322-S323
2 p.
 artikel
71 P.4.d.004 A comparison of the anxiolytic-like efficacy of mechanistically-distinct compounds in animal behavioural models Smith, D.G.
 2006
 16 Supplement 4 p. S469-
1 p.
 artikel
72 P.7.d.004 A preliminary study for standardization of the PSQ-K (paediatric sleep questionnaire -Korean version) in Korean children Kweon, Y.S.
 2006
 16 Supplement 4 p. S533-S534
2 p.
 artikel
73 P.4.d.001 Effect of ELB139, a subtype selectivie benzodiazepine agonist, on EEG in rats Langen, B.
 2006
 16 Supplement 4 p. S467-S468
2 p.
 artikel
74 P.3.d.015 Effect of quetiapine on reversing the decrease in tyrosine hydroxylase immunoreactivity following by chronic treatment of haloperidol in rat caudate putamen Zhang, Y.B.
 2006
 16 Supplement 4 p. S437-
1 p.
 artikel
75 P.7.d.001 Functional MRI of response inhibition in autism Anagnostou, E.
 2006
 16 Supplement 4 p. S531-S532
2 p.
 artikel
76 P.6.d.015 MDMA self-administration is abolished in serotonin transporter knockout mice Trigo Díaz, J.M.
 2006
 16 Supplement 4 p. S514-S515
2 p.
 artikel
77 P.6.d.005 mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behaviour in rats Dravolina, O.
 2006
 16 Supplement 4 p. S509-S510
2 p.
 artikel
78 P.5.d.001 Neuronal electrical high frequency stimulation enhances GABA release from human neocortical slices Mantovani, M.
 2006
 16 Supplement 4 p. S486-
1 p.
 artikel
79 P.2.d.013 TC-2216: anti-depressant effects through selective modulation of neuronal nicotinic receptors Lippiello, P.M.
 2006
 16 Supplement 4 p. S339-S340
2 p.
 artikel
80 P.1.d.016 The effects of a selective serotonin reuptake inhibitor and a tricyclic antidepressant on the behaviour of chronically stressed 129SvemJ and C57BL/6J mice in the hole board and forced swim test Binder, E.
 2006
 16 Supplement 4 p. S258-
1 p.
 artikel
81 P.3.d.012 The response of clozapine on midbrain dopamine neurons depends on endogenous concentration of kynurenic acid Schwieler, L.
 2006
 16 Supplement 4 p. S435-S436
2 p.
 artikel
82 P.2.e.016 Antipsychotic treatments during acute mania with prominent aggressive behaviour González-Pinto, A.
 2006
 16 Supplement 4 p. S354-
1 p.
 artikel
83 P.1.e.015 Changing of dopamine transporter binding in depressed patients with anhedonia during treatment Camardese, G.
 2006
 16 Supplement 4 p. S267-
1 p.
 artikel
84 P.3.e.006 Measurements of reaction time in clinical practice Kores Plesnicar, B.
 2006
 16 Supplement 4 p. S445-
1 p.
 artikel
85 P.2.e.003 Second generation antipsychotics versus haloperidol in the treatment of acute mania: a meta-analysis Scherk, H.
 2006
 16 Supplement 4 p. S347-
1 p.
 artikel
86 P.7.e.001 Serum concentrations of interleukin 4 and interleukin 10 in patients suffering from anorexia nervosa Komorowska-Pietrzykowska, R.
 2006
 16 Supplement 4 p. S534-
1 p.
 artikel
87 P.2.e.013 Symptoms of bipolarity in patients with eating disorders Rybakowski, F.
 2006
 16 Supplement 4 p. S352-S353
2 p.
 artikel
88 P.1.e.012 The single-voxel proton magnetic resonance spectroscopy in recurrent depression - a pilot study Silczuk, A.
 2006
 16 Supplement 4 p. S265-
1 p.
 artikel
89 P.1.f.002 Treatment of bulimia nervosa with citalopram: a randomized controlled trial Siano, C.
 2006
 16 Supplement 4 p. S275-
1 p.
 artikel
90 P.1.g.004 Serum MIF as marker for immune processes in schizophrenia De la Fontaine, L.
 2006
 16 Supplement 4 p. S282-
1 p.
 artikel
91 P.2.g.008 Serum zinc level as potential marker in recurrent depressive disorder Siwek, M.
 2006
 16 Supplement 4 p. S361-S362
2 p.
 artikel
92 Plasma serotonin levels and suicidal behavior in adolescents Tyano, Samuel
 2006
 16 Supplement 4 p. 49-57
9 p.
 artikel
93 Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite Melkersson, K.
 2006
 16 Supplement 4 p. S84-
1 p.
 artikel
94 Relative expression of tryptophan hydroxylase 1 and 2 in the brain: spatial and temporal analysis Gutknecht, L.
 2006
 16 Supplement 4 p. S32-
1 p.
 artikel
95 S.14.04 CATIE trial results Lieberman, J.A.
 2006
 16 Supplement 4 p. S184-S185
2 p.
 artikel
96 S.08.04 Dopamine D3 receptors as a target for the treatment of schizophrenia: contrasting actions of antipsychotic agents Millan, M.
 2006
 16 Supplement 4 p. S179-
1 p.
 artikel
97 S.03.02 Gene-environment interaction in depression Sugden, K.
 2006
 16 Supplement 4 p. S168-
1 p.
 artikel
98 S.11.05 Growth factors in the treatment of neurodegenerative diseases Saarma, M.
 2006
 16 Supplement 4 p. S183-S184
2 p.
 artikel
99 S.28.02 Influence of variants of TPH2 on the regulation of the central serotonin system Caron, M.G.
 2006
 16 Supplement 4 p. S203-S204
2 p.
 artikel
100 S.23.05 New functions for presenilins: do they identify novel therapeutic targets? Checler, F.
 2006
 16 Supplement 4 p. S198-
1 p.
 artikel
101 S.06.01 OCD: a multidimensional approach Hollander, E.
 2006
 16 Supplement 4 p. S174-
1 p.
 artikel
102 S.17.04 Pharmacological treatment of adolescent depression Cohen, D.
 2006
 16 Supplement 4 p. S189-S190
2 p.
 artikel
103 S.27.02 Social isolation and brain function Marsden, C.
 2006
 16 Supplement 4 p. S202-S203
2 p.
 artikel
104 S.05.03 Treatment of bipolar depression Vieta, E.
 2006
 16 Supplement 4 p. S173-
1 p.
 artikel
105 The effect of neurotrophin receptor expression and signalling on recognition learning in the rat Hennigan, A.
 2006
 16 Supplement 4 p. S58-S59
2 p.
 artikel
106 The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures Carmody, Thomas J.
 2006
 16 Supplement 4 p. 601-611
11 p.
 artikel
107 The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stress Nishitsuji, Kyoko
 2006
 16 Supplement 4 p. 376-382
7 p.
 artikel
108 The serotonin-1Dβ receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa Levitan, R.D.
 2006
 16 Supplement 4 p. 1-6
6 p.
 artikel
109 TRP channel activation via tyrosine kinases as a novel antidepressant mechanism of action — studies with hyperforin Treiber, K.
 2006
 16 Supplement 4 p. S18-
1 p.
 artikel
110 Withdrawal from cocaine self-administration or chronic mild stress increases immobility in the forced swim test in rats Frankowska, M.
 2006
 16 Supplement 4 p. S45-
1 p.
 artikel
                             110 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland